	Clinical outcomes and safety study of CDK4/6 inhibitors in hormone-positive metastatic breast cancer - A real-world tertiary cancer center experience. Indian J Cancer Sandeep KS, Appachu S, Diwaker RB, Vivek S, Simha VVS. PMID: 41797591 [PubMed - indexed for MEDLINE]
	The phase III MECCA study on metronomic chemo-endocrine therapy in advanced breast cancer-the results that so many have been waiting for. Chin Clin Oncol Wysocki PJ. PMID: 41797464 [PubMed - in process]
	Radiomics-driven prediction of pathologic complete response in non-mass breast cancer using post-neoadjuvant chemotherapy preoperative dynamic contrast-enhanced magnetic resonance imaging. Diagn Interv Radiol Moroz O, Liu Z, Liu C, Yin Q, Li X, Ai T. PMID: 41797338 [PubMed - as supplied by publisher]
	Validating a digital recovery tool for autologous breast reconstruction. J Plast Reconstr Aesthet Surg Kwasnicki RM, de Galbert L, Poon K, Giannas E, Graham J, Dunne J, Gokani V, Henry FP, Hunter JE, Williams G, Leff D, Wood SH. PMID: 41797200 [PubMed - as supplied by publisher]
	Evaluation of preoperative lymphatic drainage imaging using indocyanine green for precise sentinel lymph node biopsy in breast cancer patients. Curr Probl Surg Li X, Wang Y, Wu Y, Liang Y, Kong X, Ma T, Jiang L, Yang Q. PMID: 41796520 [PubMed - indexed for MEDLINE]
	Completion vs. early discontinuation of chemotherapy and the impact on 5-year all-cause mortality in women treated for early-stage breast cancer from 2015 to 2020: A cohort study using a target trial emulation approach. Br J Clin Pharmacol Steventon L, Ju C, Man KKC, Roylance R, Ottaviani D, Creed C, Sladkowski M, Wisner A, Wei L, Chambers P. PMID: 41796085 [PubMed - as supplied by publisher]
	Erratum to "Immediate versus delayed symmetrisation of the contralateral breast after oncoplastic procedures: A systematic review and meta-analysis" [J Plast Reconstr Aesthet Surg 114C (2026) 89-99]. J Plast Reconstr Aesthet Surg Abdulla HA, Abdulla MA, Eid R, Hashem S, Alhaddad A. PMID: 41795574 [PubMed - as supplied by publisher]
	Efficacy and safety of electrochemotherapy in the treatment of cutaneous and sub-cutaneous recurrence from breast cancer: A single-center cohort study. Eur J Surg Oncol Sena G, Amaddeo A, Iannello A, Renne M, Orsini V, Currò G, Rizzuto A. PMID: 41795433 [PubMed - as supplied by publisher]
	A Rare Case of Primary Breast Angiosarcoma: Diagnostic Challenges and Findings. J Clin Ultrasound Zhang Y, Ren Y. PMID: 41794550 [PubMed - as supplied by publisher]
	5-year results of hypofractionated locoregional radiotherapy in early breast cancer HypoG-01 (UNICANCER): a French multicentre, randomised, non-inferiority, phase 3, open-label, controlled trial. Lancet Rivera S, Ghodssighassemabadi R, Auzac G, Brion T, Kirova Y, Racadot S, Benchalal M, Clavier JB, Charra Brunaud C, Groulier A, Argo-Leignel D, Peignaux K, Benyoucef A, Pasquier D, Guilbert P, Goineau A, Tallet A, Bergeaud M, Lamrani-Ghaouti A, Michiels S, HypoG-01 trialists. PMID: 41794436 [PubMed - indexed for MEDLINE]
	An integrative multi-omics analysis leveraging Mendelian randomization and subsequent experimental validation prioritizes glutathione S-transferase mu 5 (GSTM5) as a genomic stability-related gene and a therapeutic vulnerability to PLK1 inhibition in breast cancer. Int J Biol Macromol Ma H, Li T, Huang R, Liu Y, Zhao L, Zhuang Z. PMID: 41794244 [PubMed - as supplied by publisher]
	Disparities in Diagnosis, Treatment, and Outcomes of Early-Onset Breast Cancer: A Global Perspective. Crit Rev Oncol Hematol Chinedu SN, Ogbodo PN, Effiong ME. PMID: 41794162 [PubMed - as supplied by publisher]
	Prognostic Significance of miR-145, NANOG, OCT4, and KLF4 in Triple-Negative Breast Cancer. Asian Pac J Cancer Prev Sameh R, Hussein S, Ibrahim AA, Waley AB, Ibrahim SM, Bedawy AM, Siam M, Abdelgeleel HM. PMID: 41793693 [PubMed - indexed for MEDLINE]
	Association of ESRÎ±-Pvull and ESRÎ±-Xbal Polymorphisms with Breast Cancer Susceptibility in an Iranian Population: A Hospital-Based Case-Control Study. Asian Pac J Cancer Prev Hashemzadeh-Charkhtab L, Kazemi M, Tavakoli N, Abdolshahi S, Bozorgnia A, Gilasi H. PMID: 41793684 [PubMed - indexed for MEDLINE]
	Differential Clinical Outcomes of Palliative Radiotherapy among Different Molecular Subtypes of Metastatic Breast Cancer: A Prospective Study. Asian Pac J Cancer Prev Thimmaiah N, Naveen N, Saini A, Krishna U, Kannan M, Pasha T, Poojar S. PMID: 41793681 [PubMed - indexed for MEDLINE]
	Effect of Nurse-led Intervention on Shoulder Dysfunction among Breast Cancer Patients Undergoing Modified Radical Mastectomy (MRM), South India: A Randomized Controlled Trial. Asian Pac J Cancer Prev S AN, Mj K, Dubashi B, Tp E, Ramamoorthy L. PMID: 41793679 [PubMed - indexed for MEDLINE]
	Cost Disparities Between Hospital Expenditures and Reimbursement Schemes in Indonesia: A Study on Chemotherapy for Breast Cancer. Asian Pac J Cancer Prev Kurniawan MD, Abdissalam E, Ariawan MW, Rahem A, Yulistiani Y, Wigatiningtyas A. PMID: 41793678 [PubMed - indexed for MEDLINE]
	Breast Cancer Screening in Tunisia: A Cross-Sectional Study on Women's Knowledge, Attitudes and Practices. Asian Pac J Cancer Prev Ben Youssef F, Skhiri A, Ayedi Y, Harizi C, Fakhfakh R. PMID: 41793673 [PubMed - indexed for MEDLINE]
	Pattern of Somatic Mutations in the PIK3CA Oncogene and Their Role as a Potential Prognostic Biomarker in Breast Cancer Patients in Sri Lanka: A Pilot Study. Asian Pac J Cancer Prev Cabraal TR, Kumarasinghe I, Perera R, Balawardana J, Viswakula S, Perera N, Galhena GH. PMID: 41793668 [PubMed - indexed for MEDLINE]
	Pertuzumab and Pathological Complete Response in Early HER2+ Breast Cancer: A Systematic Review and Meta-analysis of Real-World Studies. Asian Pac J Cancer Prev Matsas S, Zembala J, Ruiz Simões A, Giuliani Schmitt L, Abdou Y, Del Giglio A. PMID: 41793659 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 215300

Page 1 of 10765



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy